| abstract |
The present invention relates to novel pyrrolopyridine derivatives represented by chemical formula I, their racemates, stereoisomers, pharmaceutically acceptable salts thereof and methods for preparing them. The compounds represented by the following chemical formula I are effective against human immunodeficiency Virus (HIV) has high selectivity and physiological activity with low toxicity, and thus can be effectively used as a therapeutic agent against viral infection, especially human immunodeficiency virus (HIV) infection. |